Biocartis Group NV

11/16/2021 | Press release | Distributed by Public on 11/16/2021 00:03

New Study Demonstrates Idylla™ EGFR Mutation Test (CE-IVD) Shortens Time to Patient Management Decisions for Patients with Non-Small Cell Lung Cancer